Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
1. A method for treating osteoarthritis in a patient in need thereof, the method comprising intravenous administration to the patient a combination of prednisolone or a pharmaceutically acceptable salt thereof and Zoledronic acid or a pharmaceutically acceptable salt thereof in a single infusion.
2. The method of claim 1 , wherein the method involves treating a patient suffering from osteoarthritis.
3. The method of claim 1 , wherein the dose is between 5 mg and 50 mg of prednisolone.